CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.265
-0.025 (-1.10%)
Apr 28, 2026, 4:00 PM EDT - Market closed
CNS Pharmaceuticals Employees
As of December 31, 2024, CNS Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,170,113
Market Cap
1.84M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| Scinai Immunotherapeutics | 31 |
| Calidi Biotherapeutics | 29 |
| BiomX | 20 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Adial Pharmaceuticals | 5 |
| Oragenics | 3 |
CNSP News
- 6 weeks ago - CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline - Accesswire
- 2 months ago - CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team - Accesswire
- 2 months ago - CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation - Accesswire
- 3 months ago - CNS Pharmaceuticals Issues Letter to Shareholders - Accesswire
- 4 months ago - CNS Pharmaceuticals Announces CEO Transition - Accesswire
- 5 months ago - CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Accesswire
- 6 months ago - CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting - Accesswire
- 8 months ago - CNS Pharmaceuticals Transcript: H.C. Wainwright 27th Annual Global Investment Conference - Transcripts